Literature DB >> 6782897

Animal models of schizophrenia.

W T McKinney, E C Moran.   

Abstract

The authors review some general issues concerning the development and use of animal models of schizophrenia and present a summary of the criteria necessary for validating models. They also describe some of the major attempts at creating animal models of schizophrenia, including drug and nondrug methods. They comment on the etiologic, phenomenologic, and treatment relevance of the various systems and suggest approaches that might produce improved animal models of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6782897     DOI: 10.1176/ajp.138.4.478

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  4 in total

1.  A neurodevelopmental model of schizophrenia: neonatal disconnection of the hippocampus.

Authors:  Barbara K. Lipska; Daniel R. Weinberger
Journal:  Neurotox Res       Date:  2002 Aug-Sep       Impact factor: 3.911

2.  Latent inhibition is not affected by acute or chronic administration of 6 mg/kg dl-amphetamine.

Authors:  I Weiner; A Izraeli-Telerant; J Feldon
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

3.  Corticosterone antagonist or TrkB agonist attenuates schizophrenia-like behavior in a mouse model combining Bdnf-e6 deficiency and developmental stress.

Authors:  Yanhui Chen; Shangjin Li; Tianyi Zhang; Feng Yang; Bai Lu
Journal:  iScience       Date:  2022-06-16

Review 4.  The neonatal ventral hippocampal lesion as a heuristic neurodevelopmental model of schizophrenia.

Authors:  Kuei Y Tseng; R Andrew Chambers; Barbara K Lipska
Journal:  Behav Brain Res       Date:  2008-12-03       Impact factor: 3.332

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.